Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19
Status:
Completed
Trial end date:
2021-06-10
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine if Prolastin plus SMT can reduce the
proportion of subjects dying or requiring intensive care unit (ICU) admission on or before
Day 15 or who are dependent on invasive mechanical ventilation on Day 15 versus SMT alone in
hospitalized subjects with Coronavirus disease 2019 (COVID-19).